These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29341157)

  • 1. Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative.
    Rydén L; Loman N; Larsson C; Hegardt C; Vallon-Christersson J; Malmberg M; Lindman H; Ehinger A; Saal LH; Borg Å
    Br J Surg; 2018 Jan; 105(2):e158-e168. PubMed ID: 29341157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine.
    Saal LH; Vallon-Christersson J; Häkkinen J; Hegardt C; Grabau D; Winter C; Brueffer C; Tang MH; Reuterswärd C; Schulz R; Karlsson A; Ehinger A; Malina J; Manjer J; Malmberg M; Larsson C; Rydén L; Loman N; Borg Å
    Genome Med; 2015; 7(1):20. PubMed ID: 25722745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter study investigating the molecular fingerprint of psychological resilience in breast cancer patients: study protocol of the SCAN-B resilience study.
    Axelsson U; Rydén L; Johnsson P; Edén P; Månsson J; Hallberg IR; Borrebaeck CAK
    BMC Cancer; 2018 Aug; 18(1):789. PubMed ID: 30081937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study.
    Gonçalves A; Bertucci F; Guille A; Garnier S; Adelaide J; Carbuccia N; Cabaud O; Finetti P; Brunelle S; Piana G; Tomassin-Piana J; Paciencia M; Lambaudie E; Popovici C; Sabatier R; Tarpin C; Provansal M; Extra JM; Eisinger F; Sobol H; Viens P; Lopez M; Ginestier C; Charafe-Jauffret E; Chaffanet M; Birnbaum D
    Oncotarget; 2016 Nov; 7(48):79428-79441. PubMed ID: 27765906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validated biomarkers: The key to precision treatment in patients with breast cancer.
    Duffy MJ; O'Donovan N; McDermott E; Crown J
    Breast; 2016 Oct; 29():192-201. PubMed ID: 27521224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
    Coyne GO; Takebe N; Chen AP
    Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after treatment for breast cancer in a geographically defined population.
    Tejler G; Norberg B; Dufmats M; Nordenskjöld B;
    Br J Surg; 2004 Oct; 91(10):1307-12. PubMed ID: 15376206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genomic Medicine Sweden - a national initiative for the broad introduction of precision medicine in Swedish healthcare].
    Edsjö A; Friedman M; Rosenquist R
    Lakartidningen; 2021 May; 118():. PubMed ID: 33977514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis.
    Søreide K; Watson MM; Lea D; Nordgård O; Søreide JA; Hagland HR;
    J Transl Med; 2016 Jun; 14(1):192. PubMed ID: 27357108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Precision Medicine: Why More Is More and DNA Is Not Enough.
    Schütte M; Ogilvie LA; Rieke DT; Lange BMH; Yaspo ML; Lehrach H
    Public Health Genomics; 2017; 20(2):70-80. PubMed ID: 28595192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.
    Furtado LV; Samowitz WS
    Virchows Arch; 2017 Aug; 471(2):235-242. PubMed ID: 28551725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision medicine: In need of guidance and surveillance.
    Lin JZ; Long JY; Wang AQ; Zheng Y; Zhao HT
    World J Gastroenterol; 2017 Jul; 23(28):5045-5050. PubMed ID: 28811702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer.
    Park YH; Shin HT; Jung HH; Choi YL; Ahn T; Park K; Lee A; Do IG; Kim JY; Ahn JS; Park WY; Im YH
    Oncotarget; 2015 Oct; 6(31):32027-38. PubMed ID: 26397225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].
    Albin N; Mc Leer A; Sakhri L
    Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Evolution as the New Frontier of Precision Medicine.
    Curigliano G
    Handb Exp Pharmacol; 2018; 249():289-297. PubMed ID: 30406442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of extensive molecular profiling in advanced cancer patients.
    Cousin S; Grellety T; Toulmonde M; Auzanneau C; Khalifa E; Laizet Y; Tran K; Le Moulec S; Floquet A; Garbay D; Robert J; Hostein I; Soubeyran I; Italiano A
    J Hematol Oncol; 2017 Feb; 10(1):45. PubMed ID: 28179005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. eHealth System for Collecting and Utilizing Patient Reported Outcome Measures for Personalized Treatment and Care (PROMPT-Care) Among Cancer Patients: Mixed Methods Approach to Evaluate Feasibility and Acceptability.
    Girgis A; Durcinoska I; Levesque JV; Gerges M; Sandell T; Arnold A; Delaney GP;
    J Med Internet Res; 2017 Oct; 19(10):e330. PubMed ID: 28970188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-depth sequencing of paired primary and metastatic tumours: Implications for personalised medicine.
    Grellety T; Lucchesi C; Hostein I; Auzanneau C; Khalifa E; Soubeyran I; Italiano A
    Eur J Cancer; 2017 Oct; 84():250-256. PubMed ID: 28841542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
    Syn NL; Yong WP; Goh BC; Lee SC
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Potential of Circulating Tumor Cells in Personalized Management of Breast Cancer: A Systematic Review.
    Khatami F; Aghayan HR; Sanaei M; Heshmat R; Tavangar SM; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):175-193. PubMed ID: 28282718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.